CN1058888C - External-use ointment for treating pathological changes of intervertebral disc - Google Patents

External-use ointment for treating pathological changes of intervertebral disc Download PDF

Info

Publication number
CN1058888C
CN1058888C CN97106133A CN97106133A CN1058888C CN 1058888 C CN1058888 C CN 1058888C CN 97106133 A CN97106133 A CN 97106133A CN 97106133 A CN97106133 A CN 97106133A CN 1058888 C CN1058888 C CN 1058888C
Authority
CN
China
Prior art keywords
medicines
rhizoma
examples
bletillae
air bladder
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN97106133A
Other languages
Chinese (zh)
Other versions
CN1213541A (en
Inventor
王令喜
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN97106133A priority Critical patent/CN1058888C/en
Publication of CN1213541A publication Critical patent/CN1213541A/en
Application granted granted Critical
Publication of CN1058888C publication Critical patent/CN1058888C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention relates to externally applied ointment for treating intervertebral disc disorders and spinal canal stenosis. The present invention is characterized in that the externally applied ointment does not contain auxiliary materials and is made of pure Chinese medicines; isinglass, teasel root and rhizome of drynaria are used as principal medicines, common bletilla tuber and albizzia bark are used as ministerial medicines, rhizoma corydalis, chuanxiong rhizome, radix notoginseng, draconis resin, spatholobus stem, indian kalimeris herb and haw juice are used as adjuvant medicines, and musk and borneol are used to lead the principal medicines, the ministerial medicines and the adjuvant medicines to disease parts where the principal medicines, the ministerial medicines and the adjuvant medicines are used together. The present invention overcomes the defect that a black plaster pollutes skins and clothing and does not have the side effect of black plaster saturnism, zinc oxide anaphylactic reaction of an adhesive plaster, etc. The present invention has obvious effect of high therapeutic effect and short course of treatment and is worthy of popularizing.

Description

The external-applied ointment of treatment intervertebral disc disorder
The invention belongs to a kind of Chinese medicine lotion for external use agent for the treatment of intervertebral disc disorder, be mainly used in pushing away that intercalated disc is given prominence to, deviate from, on the external application for curing of bulging, bulge, crypts and spinal canal stenosis.
Treatment at present pushes away the intercalated disc pathological changes, generally still adopt traction, massage, physical therapy method, but this method of treatment time is long, cure rate is low.Also have and adopt " ibuprofen " for oral administration, " wind is flat ", " ibuprofen " class treatment myalgia medicine, the painful sense that this can only reduction of patient, rather than the medicine of symptomatic treatment.This class disease of Chinese traditional treatment except that the Chinese medicine for oral administration prescription, also adopts the external application medical ointment interior disease outer treating method.As: in " " Yang Shi discutient and analgesic plaster " treatment prolapse of lumbar intervertebral disc 82 examples " article that " the Jiangsu traditional Chinese medical science " 1994 the 15th the 9th phases of volume deliver, disclose a kind of " Yang Shi discutient and analgesic plaster ", it is by Moschus, borneol, Scorpio, Sal Ammoniacus, Sanguis Draxonis, Radix Notoginseng, rhizoma sparganic, Rhizoma Curcumae, Dong Dan, Oleum Sesami is formed, its method for making is earlier with Radix Notoginseng, rhizoma sparganic, Rhizoma Curcumae is put into Oleum Sesami and was soaked three days, heat again wait to explode into medicinal residues are taken out again behind the coke yellow red down, behind fire, put into Moschus, borneol, Scorpio, Sal Ammoniacus, Sanguis Draxonis carefully not with spare into cream, its therapeutic effect is, in 82 routine prolapse of lumbar intervertebral disc patients, through controlling a course of treatment (one month), clinical cure 36 examples, remarkable 43 examples that take a turn for the better, invalid 3 examples, total effective rate is 96.3%, but its cure rate only 43.9% is still not ideal enough, and still belongs to traditional black plaster from its prescription and preparation technology.For another example, November 29 nineteen ninety-five, Patent Office of the People's Republic of China is with Granted publication CN1030373C, the disclosed patent No. is " medicine for waist rheumatism " patent of 93102774.8, this patent specification, a kind of medicine " medicine for waist rheumatism " for the treatment of prolapse of lumbar intervertebral disc and lumbar spinal stenosis is disclosed, it is made up of Flos Carthami, Lignum Sappan, Olibanum, Myrrha, Radix Sanguisorbae, Pollen Typhae, Radix Notoginseng, Herba Lycopi, Sanguis Draxonis, Lignum Dalbergiae Odoriferae, Rhizoma Corydalis, Semen Strychni, the Cortex Eucommiae etc. 30 flavor Chinese crude drugs, and has provided the Example formulations of three kinds of tablets of this patent of invention " medicine for waist rheumatism ", two kinds of electuaries, two kinds of plaster.Also disclose the therapeutic effect of taking medicine 1-3 month: 1, prolapse of lumbar intervertebral disc is treated 68 examples altogether, cures 57 examples, and cure rate is 83.8%, produce effects 8 examples, total effective rate 95.6%.2, lumbar spinal stenosis is treated 46 examples altogether, cures 38 examples, produce effects 5 examples, total effective rate 93.5%, cure rate 82.6%.But the case that the examination of this therapeutic effect is controlled is limited, and its popularity is not necessarily arranged, and undeclared be for oral administration be external, still for oral administration, external is executed altogether, should " medicine for waist rheumatism " the more deficiency of used taste of Chinese medicine number be arranged also itself simultaneously.
Purpose of the present invention is exactly the deficiency at above-mentioned external-applied ointment treatment intervertebral disc disorder, provides a kind of curative effect the high external-applied ointment that can treat multiple pathological changes of intervertebral disc and spinal stenosis.
The present invention realizes by the following technical solutions, is characterized in that it does not contain adjuvant, and is made up of pure Chinese crude drug that the ratio of weight and number of each Chinese crude drug of its prescription is:
Air Bladder pseudosciaenae seu Acipenser: 19-38, Radix Dipsaci and Rhizoma Drynariae are 12-24, and Pseudobulbus Bletillae (Rhizoma Bletillae) and Cortex Albiziae are 8-16, and Caulis Spatholobi and Rhizoma Chuanxiong are 6-12, and Rhizoma Corydalis, Radix Notoginseng and Herba Kalimeridis are 5-10, Fructus Crataegi juice: 70-140, Sanguis Draxonis and Borneolum Syntheticum are 1-2, Moschus: 0.1-0.2.
The concrete ratio of weight and number of forming various medical materials of the present invention is:
Air Bladder pseudosciaenae seu Acipenser: 35, Radix Dipsaci and Rhizoma Drynariae are 20, and Pseudobulbus Bletillae (Rhizoma Bletillae) and Cortex Albiziae are 9, and Caulis Spatholobi and Rhizoma Chuanxiong are 8, and Rhizoma Corydalis, Radix Notoginseng and Herba Kalimeridis are 7, Fructus Crataegi juice: 80, Sanguis Draxonis and Borneolum Syntheticum are 1.8, Moschus: 0.16.
By on be not difficult to find out that the functional characteristics of the technical program pharmaceutical formulation is: choosing and reusing the continuous muscle T-Ring of Air Bladder pseudosciaenae seu Acipenser, Radix Dipsaci, Rhizoma Drynariae the kidney invigorating nourishing the liver is monarch drug, joins Pseudobulbus Bletillae (Rhizoma Bletillae), the continuous muscle T-Ring detumescence and promoting granulation of Cortex Albiziae principal drug assistance is a ministerial drug; Select Rhizoma Corydalis, Rhizoma Chuanxiong, Radix Notoginseng, Sanguis Draxonis, Caulis Spatholobi with promoting flow of QI and blood, the logical Lip river of blood stasis dispelling, reducing swelling and alleviating pain, the orchid that mates horses, Fructus Crataegi softening the hard mass disappear increase, heat-clearing and toxic substances removing is adjuvant drug altogether; Select Moschus, the hot perfume (or spice) of Borneolum Syntheticum to walk to scurry, saturating muscles and bones, the meridian dredging, promoting blood circulation to relieve pain, and draw the through sick be total to of all medicines for making.Because the technical program, be based on for many years research to intervertebral disc disorder mechanism, and constantly sum up and improve that prescription formulates out, it has embodied the kidney invigorating nourishing the liver Zhi Qiben, and promoting blood circulation to remove obstruction in the collateral, softening the hard mass relieve the pain and control its mark, the principle of this disease of radical cure of continuous muscle T-Ring Zhi Qigen, also since the technical program not only preferred embody the strong Chinese crude drug of above-mentioned Therapeutic Principle's function, and also science relatively of prescription consumption, so it has the curative effect height, the excellent effect of short treating period.This also can be with explanation from the situation of following trial edition ointment treatment intervertebral disc disorder patient 288 examples.
1, by patient's sex be: wherein male's 186 examples, women's 102 examples, cure 178 and 90 examples respectively, produce effects 8 and 12 examples add up to and cure 268 examples respectively, produce effects 20 examples, cure rate reaches 93%, produce effects 7%, effective percentage 100%.
2, press patient age section branch: in 16-40 year, 142 examples are cured 142 examples; In 41-60 year, 124 examples are cured 110 examples, produce effects 14 examples; 22 examples more than 61 years old are cured 16 examples, and produce effects 6 examples add up to as above.
3, by medical history length branch: 182 examples below 4 months, cure 182 examples; More than 4 months in 1 year 91 examples, cure 76 examples, produce effects 15 examples; 15 examples more than 1 year are cured 10 examples, and produce effects 5 examples add up to as above.
4, by the treatment time branch: 3-54 days, 230 examples were cured 230 examples, and 48 examples in 54-90 days are cured 34 examples, produce effects 14 examples; 10 examples more than 90 days are cured 4 examples, produce effects 6 examples.
The present invention is further described below in conjunction with embodiment, and about enforcement of the present invention, it is as follows to take by weighing clean Chinese crude drug respectively:
Air Bladder pseudosciaenae seu Acipenser 350g, Radix Dipsaci 200g, Rhizoma Drynariae 200g, each 90g of Pseudobulbus Bletillae (Rhizoma Bletillae) and Cortex Albiziae, each 80g of Caulis Spatholobi and Rhizoma Chuanxiong, each 70g of Rhizoma Corydalis, Radix Notoginseng and Herba Kalimeridis, each 18g of Sanguis Draxonis and Borneolum Syntheticum, Moschus 1.8g.
With Air Bladder pseudosciaenae seu Acipenser pulverize add water and even after, heating, it is aqueous to be viscose glue; Get clean Fructus Crataegi and be processed into Fructus Crataegi juice through fruit juice mixer, taking by weighing 800g inserts in the pot, 8 flavor meter 950g medicines such as the Radix Dipsaci that weighs up, Rhizoma Drynariae, Pseudobulbus Bletillae (Rhizoma Bletillae), Cortex Albiziae, Caulis Spatholobi, Rhizoma Chuanxiong, Rhizoma Corydalis, Radix Notoginseng, Herba Kalimeridis are put into the pot of Fructus Crataegi juice, add water (water yield is that the twice of medicine and Fructus Crataegi juice gets final product) again, be heated to and boil, heat is boiled half an hour, takes out medicinal residues, behind medical filtration, slow fire is endured to medicinal liquid and is the beading that drips again.With the powder of Air Bladder pseudosciaenae seu Acipenser glue and Sanguis Draxonis, Borneolum Syntheticum, Moschus three flavor medical materials, all put into the above-mentioned medicinal liquid of enduring and stir, promptly make ointment of the present invention.This ointment is coated on dehydration elastic force cloth (ointment bed thickness 0.4mm is advisable) after the sterilization with coating machine, cuts into the plaster shape, pack, standby plaster.The every subsides of this plaster were changed once in three days.Be not difficult to find out that from the foregoing description this ointment does not contain adjuvant, make that its substrate replaces with the medical material of this symptomatic treatment of Air Bladder pseudosciaenae seu Acipenser glue, and is water miscible by pure Chinese crude drug.So this ointment has also overcome the scarce limit that black plaster easily pollutes skin, medicated clothing, and the side effect such as zinc oxide anaphylaxis of black plaster lead poisoning, adhesive plaster with medicine.

Claims (2)

1, a kind of external-applied ointment for the treatment of the intervertebral pathological changes, it is characterized in that, its raw material and weight proportion are: Air Bladder pseudosciaenae seu Acipenser 19~38, Radix Dipsaci and Rhizoma Drynariae are 12~24, and Pseudobulbus Bletillae (Rhizoma Bletillae) and Cortex Albiziae are 8~16, and Caulis Spatholobi and Rhizoma Chuanxiong are 6~12, Rhizoma Corydalis, Radix Notoginseng and Herba Kalimeridis are 5~10, Fructus Crataegi juice 70~140, Sanguis Draxonis and Borneolum Syntheticum are 1~2, Moschus 0.1~0.2; Its preparation method is: Air Bladder pseudosciaenae seu Acipenser is pulverized added water and heat that to be viscose glue aqueous, Fructus Crataegi juice, Radix Dipsaci, Rhizoma Drynariae, Pseudobulbus Bletillae (Rhizoma Bletillae), Cortex Albiziae, Caulis Spatholobi, Rhizoma Chuanxiong, Rhizoma Corydalis, Radix Notoginseng, Herba Kalimeridis are inserted in the pot, in pot, add the heavy water of 2 times of medicines, be heated to and boil, heat is boiled half an hour, takes out medicinal residues, behind medical filtration, slow fire is endured to medicinal liquid and is the beading that drips again, the powder of Air Bladder pseudosciaenae seu Acipenser glue and Sanguis Draxonis, Borneolum Syntheticum, Moschus is added in the medicinal liquid of enduring stir promptly.
2. external-applied ointment as claimed in claim 1 is characterized in that its raw material and weight proportion are: Air Bladder pseudosciaenae seu Acipenser 35, and Radix Dipsaci and Rhizoma Drynariae are 20, Pseudobulbus Bletillae (Rhizoma Bletillae) and Cortex Albiziae are 9, and Caulis Spatholobi and Rhizoma Chuanxiong are 8, and Rhizoma Corydalis, Radix Notoginseng and Herba Kalimeridis are 7, Fructus Crataegi juice 80, Sanguis Draxonis and Borneolum Syntheticum are 1.8, Moschus 0.16.
CN97106133A 1997-10-06 1997-10-06 External-use ointment for treating pathological changes of intervertebral disc Expired - Fee Related CN1058888C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN97106133A CN1058888C (en) 1997-10-06 1997-10-06 External-use ointment for treating pathological changes of intervertebral disc

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN97106133A CN1058888C (en) 1997-10-06 1997-10-06 External-use ointment for treating pathological changes of intervertebral disc

Publications (2)

Publication Number Publication Date
CN1213541A CN1213541A (en) 1999-04-14
CN1058888C true CN1058888C (en) 2000-11-29

Family

ID=5168401

Family Applications (1)

Application Number Title Priority Date Filing Date
CN97106133A Expired - Fee Related CN1058888C (en) 1997-10-06 1997-10-06 External-use ointment for treating pathological changes of intervertebral disc

Country Status (1)

Country Link
CN (1) CN1058888C (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103356713B (en) * 2013-07-29 2015-07-08 崔学君 Acupoint sticking therapy externally-applied traditional Chinese medicinal plaster for treating peripheral facial paralysis, and preparation method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
中医研究 1994.1.1 李长庚,药垫治疗腰椎间盘突出症 *

Also Published As

Publication number Publication date
CN1213541A (en) 1999-04-14

Similar Documents

Publication Publication Date Title
CN1562160A (en) Composite medicine for treating hepatitis B complication
CN1204523A (en) Prescription of dispelling wind and strengthening bone wine and preparation method
CN1068218C (en) Adhesive plaster for curing prolapse of lumbar intervertebral disk
CN100358571C (en) Hot compress plaster for treating mastosis and its preparing method
CN101204552A (en) Chinese traditional medicine composite for breast cancer and cervical carcinoma and preparation method thereof
CN101695555A (en) Medicament composition for treating prostatitis and prostatomegaly and preparation method thereof
CN101376016B (en) Method for preparing Chinese medicine for treating hyperlipemia
CN1546066A (en) Gastrointestinal ulcer treating Chinese traditional medicine
CN101002848B (en) Medicine for treating recurrent uarthritis, and its preparing method
CN1058888C (en) External-use ointment for treating pathological changes of intervertebral disc
CN1052651C (en) Gujinkang traditional Chinese medicine and preparation method
CN100411666C (en) Broad-specturm medicine for treating snake venom poisoning
CN1686227A (en) Menstruation regulating powder
CN1772245A (en) Snake medicinal wine for health care massage and its application
CN102579672A (en) Medicament for treating bone hyperplasia and lumbar disc herniation
CN1180827C (en) Ointment for treating nuchal rigidity
CN1145798A (en) Medicine for curing prolapse of lumbar intervertebral disc and its use
CN1127664A (en) External use medicinal bag for treating acute and chronic gastritis and cholecystitis, and preparing method thereof
CN1181879C (en) Analgestic plaster
CN100398143C (en) Medicament for treating vitiligo
CN1333026A (en) Medicine for treating hyperplasia of mammary glands
CN1057912C (en) "Danshenye" Chinese medicinal liquid for treatment of cholecystitis
CN108888736B (en) External-use bone reunion medicine and preparation method thereof
CN1994415B (en) Orally administered Chinese medicine for treating dysmenorrhea
CN101843810A (en) Medicinal liquor for treating bi syndromes and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20001129

Termination date: 20151006

EXPY Termination of patent right or utility model